MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.ajkd.2019.07.022

Медицинская библиотека · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2019

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Isakova Tamara, Cai Xuan, Lee Jungwha, Mehta Rupal, Zhang Xiaoming, Yang Wei, Nessel Lisa, Anderson Amanda Hyre, Lo Joan, Porter Anna, Nunes Julie Wright, Negrea Lavinia, Hamm Lee, Horwitz Edward, Chen Jing, Scialla Julia J, de Boer Ian H, Leonard Mary B, Feldman Harold I, Wolf Myles, CRIC Study Investigators

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

RATIONALE &

OBJECTIVE

The pathogenesis of disordered mineral metabolism in chronic kidney disease (CKD) is largely informed by cross-sectional studies of humans and longitudinal animal studies. We sought to characterize the longitudinal evolution of disordered mineral metabolism during the course of CKD.

STUDY

DESIGN

Retrospective analysis nested in a cohort study.

SETTING &

PARTICIPANTS

Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study who had up to 5 serial annual measurements of estimated glomerular filtration rate, fibroblast growth factor 23 (FGF-23), parathyroid hormone (PTH), serum phosphate, and serum calcium and who subsequently reached end-stage kidney disease (ESKD) during follow-up (n = 847).

EXPOSURE: Years before ESKD.

OUTCOMES: Serial FGF-23, PTH, serum phosphate, and serum calcium levels.

ANALYTICAL APPROACH: To assess longitudinal dynamics of disordered mineral metabolism in human CKD, we used "ESKD-anchored longitudinal analyses" to express time as years before ESKD, enabling assessments of mineral metabolites spanning 8 years of CKD progression before ESKD.

RESULTS

Mean FGF-23 levels increased markedly as time before ESKD decreased, while PTH and phosphate levels increased modestly and calcium levels declined minimally. Compared with other mineral metabolites, FGF-23 levels demonstrated the highest rate of change (velocity: first derivative of the function of concentration over time) and magnitude of acceleration (second derivative). These changes became evident approximately 5 years before ESKD and persisted without deceleration through ESKD onset. Rates of changes in PTH and phosphate levels increased modestly and without marked acceleration around the same time, with modest deceleration immediately before ESKD, when use of active vitamin D and phosphate binders increased.

LIMITATIONS: Individuals who entered the CRIC Study at early stages of CKD and who did not progress to ESKD were not studied.

CONCLUSIONS

Among patients with progressive CKD, FGF-23 levels begin to increase 5 years before ESKD and continue to rapidly accelerate until transition to ESKD.

Для цитирования: Isakova Tamara, Cai Xuan, Lee Jungwha, Mehta Rupal, Zhang Xiaoming, Yang Wei, Nessel Lisa, Anderson Amanda Hyre, Lo Joan, Porter Anna, Nunes Julie Wright, Negrea Lavinia, Hamm Lee, Horwitz Edward, Chen Jing, Scialla Julia J, de Boer Ian H, Leonard Mary B, Feldman Harold I, Wolf Myles, CRIC Study Investigators. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019. DOI: 10.1053/j.ajkd.2019.07.022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.